The Medical clinics of North America | 2021

Decision Making in Subclinical Thyroid Disease.

 
 

Abstract


Subclinical thyroid disease is frequently encountered in clinic practice. Although overt thyroid dysfunction has been associated with adverse clinical outcomes, uncertainty remains about the implications of subclinical thyroid disease. Available data suggest that subclinical hypothyroidism may be associated with increased risk of cardiovascular disease and death. Despite this finding, treatment with thyroid hormone has not been consistently demonstrated to reduce cardiovascular risk. Subclinical hyperthyroidism has been associated with increased risk of atrial fibrillation and osteoporosis, but the association with cardiovascular disease and death is uncertain. The decision to treat depends on the degree of thyroid-stimulating hormone suppression and underlying comorbidities.

Volume 105 6
Pages \n 1033-1045\n
DOI 10.1016/j.mcna.2021.05.014
Language English
Journal The Medical clinics of North America

Full Text